Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Clinical Cancer Research, 2025
Ad-SGE-DKK3 Gene Therapy Overcomes Resistance to Immune Checkpoint Blockade in Pleural Mesothelioma

Jang H., Patel M., Wang D. et al.

Olink Explore HTOncologyImmunotherapyPathophysiologyPlasma

Nutrition & Metabolism, 2025
Unveiling the interplay among skin microbiota, cytokines, and T2DM: an insightful Mendelian randomization study

Zhang Z., Jiang C., Xing Y. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPlasma

Nature, 2025
Translational genomics of osteoarthritis in 1,962,069 individuals

Hatzikotoulas K., Southam L., Stefansdottir L. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma

Nature Cancer, 2025
Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysis

Cousin S., Guégan J., Palmieri L. et al.

Olink Target 96OncologyPathophysiologyPlasma

Brain and Behavior, 2025
Systemic Inflammatory Factors and Neuropsychiatric Disorders: A Bidirectional Mendelian Randomization Study

Wang H., Cheng Z., Xu Z. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Cell, 2025
Human proteome distribution atlas for tissue-specific plasma proteome dynamics

Malmström E., Malmström L., Hauri S. et al.

Olink Explore 3072/384Wider Proteomics StudiesData SciencePlasma

GeroScience, 2025
Associations between plasma proteomic signatures and secondary sleep in older adults

Madhawa K., Svensson T., Nt H. et al.

Olink Target 96NeurologyAgingPathophysiologyPlasma

Scientific Reports, 2025
Novel serum biomarker associations with 7 Tesla MRI-defined cortical lesions, leptomeningeal enhancement, and deep gray matter volume in early multiple sclerosis

Miclea A., Zurawski J., Healy B. et al.

Olink Target 96NeurologyPatient StratificationSerum

Thrombosis Journal, 2025
Association of MTHFR missense variants with thromboembolic diseases and coagulation factor levels in European populations

Daghlas I., Wang M., Gill D.

Olink Explore 3072/384CVDHematologyPathophysiologyPlasma

npj Precision Oncology, 2025
Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatment

Cui S., Zheng H., Xu Y. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationPlasma

Arthritis & Rheumatology, 2025
Serum Proteomic Signatures Before the Diagnosis of Rheumatoid Arthritis: Evolving Biologic Pathways and Specific Periods of Disease Development

Rachid Zaim S., Savage A., Gillespie M. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum

Cell Genomics, 2025
Integration of biobank-scale genetics and plasma proteomics reveals evidence for causal processes in asthma risk and heterogeneity

Donoghue L., Benner C., Chang D. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma

Cell Reports Medicine, 2025
Altered baseline immunological state and impaired immune response to SARS-CoV-2 mRNA vaccination in lung transplant recipients

Hu M., Oliveira A., Fang Z. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Mediators of Inflammation, 2025
Causal Associations of Inflammatory Cytokines With Osteosarcopenia: Insights From Mendelian Randomization and Single Cell Analysis

Wu Z., Yang J., Zhu Y. et al.

Olink Target 96AgingPathophysiologyPlasma

Neurological Research, 2025
Mediators of the causal associations between protein ratios and ischemic stroke: a two-step Mendelian randomization study

Tan H., Chen H., Yan H. et al.

Olink Explore 3072/384NeurologyPathophysiologyPlasma

International Journal of Cancer, 2025
Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer

Cooley V., Fortner R., Mukama T. et al.

Olink Target 96OncologyPatient StratificationPlasma

Nature Medicine, 2025
Immune and metabolic effects of African heritage diets versus Western diets in men: a randomized controlled trial

Temba G., Pecht T., Kullaya V. et al.

Olink Target 96Nutritional SciencePathophysiologyPlasma

Journal of Proteome Research, 2025
Identification of Salivary Biomarkers in Colorectal Cancer by Integrating Olink Proteomics and Metabolomics

Su H., Gu X., Zhang W. et al.

Olink Target 96OncologyPatient StratificationSaliva

Urolithiasis, 2025
Effect of the plasma metabolites, biomarkers, and inflammatory proteins on urolithiasis: insights from Mendelian randomization and mediation analysis

Huang H., Wen Z., Li H. et al.

Olink Target 96UrologyPathophysiologyPlasma

Diabetes Care, 2025
Large-Scale Proteomics Improve Risk Prediction for Type 2 Diabetes

Xie R., Vlaski T., Trares K. et al.

Olink Target 96Olink Explore 3072/384Metabolic DiseasesPatient StratificationPlasma

2965 publications